Catalyst Biosciences Inc (CBIO.OQ)
CBIO.OQ on NASDAQ Stock Exchange Capital Market
5.86USD
19 Sep 2019
5.86USD
19 Sep 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$5.86
$5.86
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
45,252
45,252
52-wk High
$11.44
$11.44
52-wk Low
$5.86
$5.86
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 0.00 | -1.261 |
| FY 2018 | Dec '18 | 0.00 | -0.907 |
| Sep '18 | 0.00 | -0.644 | |
| Jun '18 | 0.00 | -0.543 | |
| Mar '18 | 0.01 | -0.561 | |
| FY 2017 | Dec '17 | 0.32 | -1.261 |
| Sep '17 | 0.32 | -1.344 | |
| Jun '17 | 0.11 | -2.534 | |
| Mar '17 | 0.27 | -4.567 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 3 | 0.30 | 0.90 | 0.00 | 0.00 |
| Quarter Ending Dec-19 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 3 | 0.30 | 0.90 | 0.00 | 0.00 |
| Year Ending Dec-20 | 2 | 0.73 | 1.45 | 0.00 | 19.03 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 3 | -1.04 | -0.93 | -1.19 | -0.59 |
| Quarter Ending Dec-19 | 3 | -1.07 | -0.83 | -1.23 | -0.62 |
| Year Ending Dec-19 | 3 | -4.48 | -4.01 | -4.88 | -3.09 |
| Year Ending Dec-20 | 2 | -3.55 | -3.47 | -3.62 | -2.19 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 29.73 | 33.85 | |
| P/E High - Last 5 Yrs. | -- | 47.56 | 54.29 | |
| P/E Low - Last 5 Yrs. | -- | 27.30 | 28.22 | |
| Beta | 1.88 | 1.00 | 0.99 | |
| Price to Sales (TTM) | -- | 6.00 | 7.90 | |
| Price to Book (MRQ) | 0.90 | 3.84 | 4.38 | |
| Price to Tangible Book (MRQ) | 0.90 | 4.14 | 5.07 | |
| Price to Cash Flow (TTM) | -- | 21.62 | 23.70 | |
| % Owned Institutions | 82.85 | 0.79 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.83 | 1.67 | |
| Dividend Yield - 5 Year Avg | -- | 1.47 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 6.74 | 6.82 | |
| Payout Ratio(TTM) | -- | 50.64 | 46.67 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 13.42 | 14.65 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -100.00 | 6.45 | 8.45 | |
| Sales - 5 Yr. Growth Rate | -59.08 | 8.32 | 9.43 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -124.78 | 18.49 | 19.40 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 41.15 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 5.66 | 7.15 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 7.02 | 8.01 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.52 | 2.52 |
| Current Ratio (MRQ) | 24.94 | 3.55 | 3.52 |
| LT Debt to Equity (MRQ) | 1.59 | 11.64 | 12.61 |
| Total Debt to Equity (MRQ) | 1.59 | 16.17 | 17.64 |
| Interest Coverage (TTM) | -- | 7.61 | 14.93 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 51.41 | 50.25 | |
| Gross Margin - 5 Yr. Avg. | -- | 50.53 | 51.36 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -1,913.84 | 17.64 | 16.42 | |
| Operating Margin (TTM) | -- | -2.19 | -6.97 | |
| Operating Margin - 5 Yr. Avg. | -1,952.93 | 13.94 | 11.87 | |
| Pre-Tax Margin (TTM) | -- | -2.50 | -7.30 | |
| Pre-Tax Margin - 5 Yr. Avg. | -1,803.77 | 18.73 | 15.72 | |
| Net Profit Margin (TTM) | -- | -6.21 | -11.11 | |
| Net Profit Margin - 5 Yr. Avg. | -1,803.77 | 14.06 | 11.11 | |
| Effective Tax Rate (TTM) | -- | 20.27 | 20.61 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.92 | 24.51 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 1,012,949,194 | 870,638,159 | |
| Net Income/Employee (TTM) | -1,909,333 | 118,477,208 | 101,855,832 | |
| Receivable Turnover (TTM) | -- | 5.61 | 5.88 | |
| Inventory Turnover (TTM) | -- | 2.59 | 3.66 | |
| Asset Turnover (TTM) | 0.00 | 0.88 | 0.85 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -31.11 | 10.57 | 10.25 | |
| Return on Assets - 5 Yr. Avg. | -31.50 | 11.70 | 11.17 | |
| Return on Investment (TTM) | -32.01 | 13.04 | 12.69 | |
| Return on Investment - 5 Yr. Avg. | -43.49 | 14.80 | 14.15 | |
| Return on Equity (TTM) | -32.25 | 14.12 | 17.13 | |
| Return on Equity - 5 Yr. Avg. | -97.60 | 15.92 | 15.53 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -99.41 | -84.92 | -59.08 |
| EPS (TTM) % | 64.03 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Catalyst Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 9.09 | 6.06 | 87 | 47 |
| 13 Week | -4.06 | -6.78 | 59 | 34 |
| 26 Week | 4.82 | -7.69 | 70 | 15 |
| 52 Week | -18.79 | -23.84 | 49 | 66 |
| YTD | 1.90 | -15.58 | 58 | 20 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 88.97% |
| # of Holders: | 96 |
| Total Shares Held: | 10,658,884 |
| 3 Mo. Net Change: | 1,332,346 |
| # New Positions: | 2 |
| # Closed Positions: | 1 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 4 |
| # Net Buyers: | 3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.